Delivery Order SPE2DB22D1106-SPE2DB25FFEQ7
Award Date 8/21/25
Potential Completion Date 8/22/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,318.16 for Ganirelix Acetate 250 micrograms/0.5 milliliters on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The product is a gonadotropin-releasing hormone antagonist used in fertility treatment...
- The Defense Logistics Agency awarded a delivery order valued at $3,152.51 to AmerisourceBergen Drug Corp for the supply of Ganirelix Acetate 250 mcg/0.5 mL injection on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ganirelix Acetate 250 mcg/0.5 mL injectable medication, valued at $6,739.56 with a firm fixed price arrangement. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents...
- The Defense Logistics Agency awarded a $3,062.47 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ganirelix Acetate 250 mcg/0.5 mL injectable medication. This contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries firm fixed pricing and involves no set-aside designation, indicating...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,058.04, is for the delivery of the drug Ganirelix Acetate 250 MCG/0.5 ML 0.5ML. It has an ultimate completion date of December 11, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This delivery order, awarded on June 27, 2025, provides for the supply of Ganirelix Acetate 250 micrograms/0.5 milliliters to support federal healthcare operations. The contract, valued at $3,724.00, represents a firm fixed price delivery order with no set-aside designation, awarded competitively to AmerisourceBergen Drug Corp through the Defense Logistics Agency's Medical Supply Chain. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558972905 GANIRELIX ACET 250 MCG/0.5 ML 0.5ML. The contract, valued at $3,388.08, is a firm fixed price delivery order with a completion date of November 3, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GANIRELIX ACET 250 MCG/0.5 ML 0.5ML medical products. The contract has a Firm Fixed Price pricing type and a ceiling value of $5,603.26. It does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,146.49 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product. This firm fixed price delivery order, issued on July 31, 2025, with completion targeted for August 1, 2025, represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award utilized no set-aside designation, indicating it was competitively awarded through standard procurement procedures. The...
- The Defense Logistics Agency awarded a $2,743.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 Unit 1.44ML, a specialty pharmaceutical product. The contract was awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, and will be performed in Conshohocken, Pennsylvania. This delivery order is a non-set-aside, competitively awarded transaction and represents a child contract under AmerisourceBergen's broader Indefinite...